Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan (Q34117144)

31 July 2017

Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan (English)

1 reference

31 July 2017

6

George Sgouros

1 reference

31 July 2017

2

Robert F Hobbs

1 reference

31 July 2017

1

Sébastien Baechler

1 reference

31 July 2017

Andrew R Prideaux

3

1 reference

PubMed ID

18999935

31 July 2017

Mélanie Recordon

series ordinal

4

1 reference

PubMed ID

18999935

31 July 2017

Angelika Bischof-Delaloye

series ordinal

5

1 reference

31 July 2017

1 October 2008

1 reference

Cancer Biotherapy and Radiopharmaceuticals

31 July 2017

1 reference

31 July 2017

23

1 reference

31 July 2017

5

1 reference

31 July 2017

633-639

1 reference

Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936951

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936951

The influence of age, sex, race, and body habitus on kidney weight in humans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936951

High-dose radioimmunotherapy with 90Y-ibritumomab tiuxetan: comparative dosimetric study for tailored treatment.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936951

Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936951

Patient-specific dosimetry of pretargeted radioimmunotherapy using CC49 fusion protein in patients with gastrointestinal malignancies.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936951

Absolute organ activity estimated by five different methods of background correction.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936951

A preliminary phantom study on a proposed model for quantification of renal planar scintigraphy.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936951

Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936951

Quantification of the distribution of 111In-labelled platelets in organs.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936951

28 October 2018

Identifiers

DOI

10.1089/CBR.2008.0506

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

PubMed ID

18999935